Intercure Operating Expenses Growth & History (INCR)
Intercure's operating expenses was ₪26.4M for fiscal 2025.
View full Intercure company overviewIntercure annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | ₪26.4M | −₪71.0M | −72.86% |
| 2024 | 2024-12-31 | ₪97.4M | −₪49.2M | −33.56% |
| 2023 | 2023-12-31 | ₪146.7M | ₪42.2M | +40.41% |
| 2022 | 2022-12-31 | ₪104.5M | ₪41.5M | +65.95% |
| 2021 | 2021-12-31 | ₪62.9M | −₪7.4M | −10.56% |
| 2020 | 2020-12-31 | ₪70.4M | ₪65.5M | +1337.99% |
| 2019 | 2019-12-31 | ₪4.9M | — | — |
Intercure operating expenses trends
Over the last five fiscal years, Intercure's operating expenses decreased from ₪70.4M to ₪26.4M, a change of −₪43.9M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intercure source filings ↗Community posts
InterCure resolves Nasdaq minimum-bid-price deficiency
InterCure ($INCR) received written confirmation that it has regained compliance with Nasdaq’s minimum-bid-price requirement. Its shares had closed at or above $1 for ten consecutive business days, allowing Nasdaq to close the specific defic ...